Clobazam
- Product NDC
- 0527-5301
- 11-digit product format
- 005275301
- Labeler code
- 0527
- Product ID
- 0527-5301_0c6e540f-d675-4932-855c-b17a4a12197e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clobazam
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- ANDA213110
- Marketing category
- ANDA
- Marketing start
- 2020-04-24
- Marketing end
- 2023-06-30
- Substance
- CLOBAZAM
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0527-5301-64 | 00527530164 | 1 BOTTLE in 1 CARTON (0527-5301-64) > 120 mL in 1 BOTTLE | 1 bottle | 2020-04-24 | 2023-06-30 | No | No | Current |